20537 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having three or more nucleosides or nucleotides Double-stranded nucleic acids or oligonucleotides
Method for treating cell proliferation related disorders
#2702Polycomb-associated non-coding RNAs
#2703METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#2704Plant sRNA extract or plant miRNA for use as an immunosuppressive agent
#2705Methods of altering bone growth by administration of Sost or Wise antagonist or agonist
#2706Bioactive conjugates for oligonucleotide delivery
#2707Methods for treating T-cell acute lymphoblastic leukemia
#2708NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
#2709NEAT1 as a prognostic marker and therapeutic target for prostate cancer
#2710COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES
#2711VITAMIN E-BASED NANOCARRIERS FOR DRUG DELIVERY AND METHODS OF MAKING AND USING THE SAME
#2712Method of treating diabetic nephropathy by administering antibodies to vascular endothelial growth factor B (VEGF-B)
#2713Method and carrier complexes for delivering molecules to cells
#2714COMBINATION CANCER TREATMENTS UTILIZING SYNTHETIC OLIGONUCLEOTIDES AND EGFR-TKI INHIBITORS
#2715RNAi Therapy for Hepatitis B Virus Infection
#2716METHODS AND REAGENTS FOR THE DIAGNOSIS AND TREATMENT OF ACUTE LEUKEMIA
#2717Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma
#2718MultiLigand agent for drug delivery
#2719Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase
#2720Treatment of autoimmune disorders and infections using antagonists of SGK1 activity
#2721RNA complexes that inhibit melanin production
#2722Polycomb-associated non-coding RNAs
#2723Targeting molecule and a use thereof
#2724Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
#2725Compositions for introducing RNA into cells
#2726PROCESS FOR THE IDENTIFICATION OF COMPOUNDS FOR TREATING CANCER
#2727Targeted polymerized nanoparticles for cancer treatment
#2728Pharmaceutical composition and method for reducing scar formation
#2729Method of Treating Cancer by Inhibition of DNA Repair Proteins
#2730Compositions and methods for treating cachexia
#2731METHODS FOR IN VIVO GENOME EDITING
#2732Antibody-drug conjugates and uses thereof
#2733Method for prevention of colectomy
#2734Induction of thyroid iodide-handling gene expression in human cancers
#2735Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#2736Method for detecting an FGFR3/TACC3 fusion protein, or encoding gene thereof
#2737RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
#2738Compositions and methods for inhibition of nucleic acids function
#2739COMPOSITIONS FOR INHIBITING DUX4 GENE EXPRESSION AND USES THEREOF
#2740Inhibition of NEAT1 for treatment of solid tumors
#2741Trialkyl cationic lipids and methods of use thereof
#2742Microbubble complexes and methods of use
#2743SiRNA targeting PRK2, which is hepatitis C virus therapeutic agent
#2744PROTEIN PHOSPHATASE INHIBITOR
#2745Method for treatment of heart failure
#2746Polypeptides
#2747VH4 ANTIBODIES AGAINST GRAY MATTER NEURON AND ASTROCYTE
#2748Compounds for targeting drug delivery and enhancing siRNA activity
#2749Diether based biodegradable cationic lipids for siRNA delivery
#2750EGFR-TARGETED NANOPARTICLES
#2751Compounds for targeting drug delivery and enhancing siRNA activity
#2752Nanostructured gels capable of controlled release of entrapped agents
#2753LIPID FORMULATED DSRNA TARGETING THE PCSK9 GENE
#2754Biomarkers for premature birth and use thereof
#2755Identification and use of target genes for control of plant parasitic nematodes
#2756RNAi inhibition of alpha-ENaC expression
#2757Polycomb-associated non-coding RNAS
#2758Modified L-Nucleic Acid
#2759Methods of Manipulating the Fate of Cells
#2760Biocompatible flavonoid compounds for organelle and cell imaging
#2761Ionizable compounds and compositions and uses thereof
#2762Lipids and lipid nanoparticle formulations for delivery of nucleic acids
#2763MIKTO-ARM BRANCHED POLYMERS
#2764TARGETING LIPIDS
#2765METHODS AND COMPOSITIONS INVOLVING CHITOSAN NANOPARTICLES
#2766Peptide/particle delivery systems
#2767Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)
#2768RNAi targeting SEC61G
#2769RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
#2770RNAi targeting CNTD2
#2771RNAi targeting ZNF205
#2772COMPOSITIONS AND METHODS FOR DELIVERING MICRORNA
#2773Polycation-functionalized nanoporous silicon carrier for systemic delivery of gene silencing agents
#2774A METHOD OF INCREASING GIPCR SIGNALIZATION IN THE CELLS OF A SCOLIOTIC SUBJECT
#2775Talen-based gene correction
#2776Systemic In Vivo Delivery of Oligonucleotides
#2777Methods and compositions for neuroprotection
#2778METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, CLASSIFICATION, AND TREATMENT OF CANCER
#2779Reagents and Methods for Treating Cancer
#2780Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway
#2781Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
#2782Treatment of disease by modulation of SIRT6
#2783Method for selectively inhibiting ACAT1 in the treatment of obesity, metabolic syndrome, and atherosclerosis
#2784SDF-1 binding nucleic acids and the use thereof in cancer treatment
#2785RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
#2786miR-29 mimics and uses thereof
#2787Polycomb-associated non-coding RNAs
#2788Compositions and methods for treating liver injury
#2789Oligonucleotide compounds for targeting huntingtin mRNA
#2790Polycomb-associated non-coding RNAs
#2791Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disorders
#2792Targeted therapeutic nucleosides and their use
#2793Anionic polyplexes for use in the delivery of nucleic acids
#2794Therapeutic method of inducing mitochondrial biogenesis to treat skin and muscle pathologies
#2795Compositions and Methods for Inhibition of PCSK9 Genes
#2796Venule endothelial cell genes and uses thereof
#2797Compositions and methods for inhibiting expression of the PCSK9 gene
#2798RNA aptamers against BAFF-R as cell-type specific delivery agents and methods for their use
#2799Compositions and methods for inhibiting gene expression of Hif2alpha
#2800Polymers including galactose based blocks and uses thereof
#2801MODIFIED PARAMAGNETIC NANOPARTICLES FOR TARGETED DELIVERY OF THERAPEUTICS AND METHODS THEREOF
#2802USE OF RNA INTERFERENCE, FARNESOIC ACID AND RECOMBINANT PROTEIN APPROACH TO INDUCE GONAD MATURATION IN CRUSTACEAN SPECIES
#2803Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung
#2804LONG NON-CODING RNA SPRY4-IT1 AS A DIAGNOSTIC AND THERAPEUTIC AGENT
#2805Nanoscale carriers for the delivery or co-delivery of chemotherapeutics, nucleic acids and photosensitizers
#2806Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and BPH
#2807Ketohexokinase (KHK) iRNA compositions and methods of use thereof
#2808Compositions and Methods to Inhibit EZH2 for the Treatment of Cardiovascular Diseases
#2809Methods for the prevention and the treatment of extracapillary glomerulonephritis
#2810Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates
#2811METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS
#2812Compositions and methods for treating autoimmune and inflammatory diseases
#2813Tailored combinatorial epigenetic therapies for P53 gain-of-function tumors
#2814Method of diagnosis, prognostic or treatment of neurodegenerative disease
#2815METHODS FOR DELIVERY OF siRNA TO THE SPINAL CORD AND THERAPIES ARISING THEREFROM
#2816Anti-tumor therapy
#28175′ triphosphate oligonucleotide with blunt end and uses thereof
#2818Bi-Functional Short-Hairpin RNA (Bi-shRNA) Specific for Single-Nucleotide KRAS Mutations
#28195′ triphosphate oligonucleotide with blunt end and uses thereof
#2820Materials and methods for modulation of tendon healing
#2821miR-122* as an active micro-RNA, compositions comprising the same and uses thereof
#2822METHODS
#2823Molecular targets for healing or treating wounds
#2824SDF-1 binding nucleic acids and the use thereof
#2825rAAV-based compositions and methods
#2826Sequence specific antimicrobials
#2827Methods and products for nucleic acid production and delivery
#2828Lipids and compositions for intracellular delivery of biologically active compounds
#2829Artificial match-type miRNA for controlling gene expression and use therefor
#2830Multilayered nanoparticle and methods of manufacturing and using the same
#2831Targeted nanocarriers for the administration of immunosuppressive agents
#2832Lipids and lipid compositions for the delivery of active agents
#2833Treating neurodegenerative disease
#2834Methods of determining eosinophilic gastritis status based on marker or gene expression
#2835Composition for regenerating normal tissue from fibrotic tissue
#2836Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
#2837Inhibitor for inhibiting avian influenza virus and a pharmaceutical composition containing the same
#2838Hippo and dystrophin complex signaling in cardiomyocyte renewal
#2839SYSTEM FOR CO-DELIVERY OF POLYNUCLEOTIDES AND DRUGS INTO PROTEASE-EXPRESSING CELLS
#2840Lipids and lipid compositions for the delivery of active agents
#2841Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the retinal pigment epithelium of a subject
#2842Compositions and methods for delivering inhibitory oligonucleotides
#2843TETRASPANIN CD82 AS A DIAGNOSTIC AND/OR THERAPEUTIC MODULE FOR XENOGRAFT RECOGNITION AND/OR REJECTION
#2844METHODS FOR TREATMENT OF WOUND HEALING UTILIZING CHEMICALLY MODIFIED OLIGONUCLEOTIDES
#2845Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
#2846Cell-based anti-cancer compositions with reduced toxicity and methods of making and using the same
#2847Cationic lipid formulations for regressing established tumor
#2848Antibody-SN-38 immunoconjugates with a CL2A linker
#2849Inhibitors of immune checkpoint modulators and related methods
#2850Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
#2851MEANS FOR LUNG SPECIFIC DELIVERY
#2852Lipid vesicle compositions and methods of use
#2853Complement component iRNA compositions and methods of use thereof
#2854RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
#2855UCP1 (THERMOGENIN) - INDUCING AGENTS FOR USE IN THE TREATMENT OF A DISORDER OF THE ENERGY HOMEOSTASIS
#2856EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#2857COMPOSITIONS AND METHODS FOR LONG ACTING MOLECULES
#2858Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer
#2859Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
#2860Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium
#2861Methods for identifying therapeutic targets and treating monitoring cancers
#2862Mutator Activity Induced by microRNA-155 (miR-155) Links Inflammation and Cancer
#2863Siglec-15 antibodies in treating bone loss-related disease
#2864Glucocorticoid inhibitors for treatment of prostate cancer
#2865MODULATION OF TIMP1 AND TIMP2 EXPRESSION
#2866MODULATION OF AXON DEGENERATION
#2867Treatment of cancer using a SMAD3 inhibitor
#2868Organic compositions to treat beta-ENaC-related diseases
#2869Compositions and methods for inhibiting gene expression of factor XII
#2870METHOD FOR TREATING OR PREVENTING NONALCOHOLIC FATTY LIVER DISEASE
#2871Inhibition of a lncRNA for treatment of melanoma
#2872COMPOSITIONS AND METHODS FOR SILENCING EBOLA VIRUS GENE EXPRESSION
#2873Compositions and Methods for Inhibiting Expression of Transthyretin
#2874MICRONEEDLE ARRAYS FOR ACTIVE AGENT DELIVERY
#2875Compositions and methods for promoting the mineralization of biological tissue
#2876Methods for the treatment of hepatitis B and hepatitis D infections
#2877RNAi-MEDIATED INHIBITION OF SPLEEN TYROSINE KINASE-RELATED INFLAMMATORY CONDITIONS
#2878MCPIP protection against osteoclast production
#2879Methods for inducing cardiomyocyte proliferation
#2880SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#2881Cationic lipid
#2882Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety
#2883Block copolymers and uses thereof
#2884Antibody-SN-38 immunoconjugates with a CL2A linker
#2885Methods for treating hair loss disorders
#2886Methods for treating hair loss disorders
#2887Methods of diagnosing and treating B cell acute lymphoblastic leukemia
#2888Non-liposomal systems for nucleic acid delivery
#2889METHODS AND COMPOSITIONS FOR DELIVERY OF ACTIVE AGENTS
#2890Micellic assemblies
#2891METHODS AND COMPOSITIONS TO REDUCE LIVER DAMAGE ASSOCIATED WITH CONDITIONS OR THERAPIES THAT AFFECT THE IMMUNE SYSTEM
#2892Complement component C5 iRNA compositions and methods of use thereof
#2893Compositions and methods for the manufacture of lipid nanoparticles
#2894HYALURONIC ACID-NUCLEIC ACID CONJUGATE AND COMPOSITION FOR NUCLEIC ACID DELIVERY CONTAINING THE SAME
#2895DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS
#2896Cationic nanoparticles for co-delivery of nucleic acids and therapeutic agents
#2897Non-silencing selectable marker genes and methods of use
#2898Compounds for inducing anti-tumor immunity and methods thereof
#2899Peptide oligonucleotide conjugates
#2900Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
#2901METHODS FOR INCREASING NEURONAL SURVIVAL
#2902Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists
#2903Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer
#2904Treatment of inflammatory skin disease
#2905ALPHA HELIX CELL-PENETRATING PEPTIDE MULTIMER, PREPARATION METHOD THEREFOR AND USE THEREFOR
#2906Hypoxia-Targeted Delivery System for Pharmaceutical Agents
#2907Carrier nanoparticles and related compositions, methods and systems
#2908Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis
#2909Glutamate dehydrogenase 1 inhibitors and methods of treating cancer
#2910Methods and pharmaceutical compositions for treatment of cystic fibrosis
#2911Inhibition of ferrochelatase as an antiangiogenic therapy
#2912Anti-tumor therapy
#2913Compositions for targeted delivery of siRNA
#2914Universal protein tag for double stranded nucleic acid delivery
#2915Hydrazinyl lipidoids and uses thereof
#2916Lipocationic polymers and uses thereof
#2917Methods of using propentofylline to treat glioma and glioblastoma
#2918Identification of small molecules that facilitate therapeutic exon skipping
#2919Therapeutic and Diagnostic Method for Ataxia-Telangiectasia
#2920Kits for classifying a subject having or at risk for developing idiopathic scoliosis
#2921Notch 1 specific siRNA molecule
#2922METHODS OF MODULATING LYMPHANGIOGENESIS, E.G., TO TREAT CORNEAL TRANSPLANT REJECTION, IN A SUBJECT
#2923Methods of modulating compliance of the trabecular meshwork
#2924Compositions and methods for treating lung disease and injury
#2925CXCL12 (CHEMOKINE (C-X-C MOTIF) LIGAND 12) AND IGFBP2 INHIBITORS FOR THE APPLICATION IN THE TREATMENT OF DIABETES MELLITUS ASSOCIATED PANCREATIC CANCER
#2926Lipids and compositions for the delivery of therapeutics
#2927Novel Delivery Compositions and Methods of Using Same
#2928Genetic inhibition by double-stranded RNA
#2929Antisense Oligonucleotides Against Neutral Sphingomyelinase and Neutral Sphingomyelinase Inhibitor GW4869 for Degenerative Neurological Disorders
#2930RNA interference agents for GST-PI gene modulation
#2931Liposome for topical administration and application thereof
#2932Complex containing oligonucleotide having immunopotentiating activity and use thereof
#2933RNA agents for P21 gene modulation
#2934RNA agents for GST-Pi gene modulation
#2935Compositions and Methods for Inducing Senescence in Cancer Cells
#2936Neurocalcin delta inhibitors and therapeutic and non-therapeutic uses thereof
#2937METHODS AND COMPOSITIONS FOR ENHANCING DELIVERY OF DOUBLE-STRANDED RNA OR A DOUBLE-STRANDED HYBRID NUCLEIC ACID TO REGULATE GENE EXPRESSION IN MAMMALIAN CELLS
#2938Nanocomplexes for co-delivering a drug and siRNA and uses thereof
#2939Bruton's Tyrosine Kinase as Anti-Cancer Drug Target
#2940CELL DEATH-INDUCING AGENT, CELL GROWTH-INHIBITING AGENT, AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DISEASE CAUSED BY ABNORMAL CELL GROWTH
#2941Composition for Enhancing Transgene Expression in Eukaryotic Cells and Method for Enhancing Production of a Target Protein Encoded by a Transgene
#2942Methods and compositions for selecting siRNA of improved functionality
#2943Antisense RNA for treating cancer and inhibition of metastasis and vectors for antisense sequestration
#2944Methods and compositions for selecting siRNA of improved functionality
#2945Micro-RNA regulation of bone loss
#2946Graft copolymer polyelectrolyte complexes for drug delivery
#2947Lipids and compositions for the delivery of therapeutics
#2948Method of reducing antigenic drift or reassortment of viruses in a host animal using α interferon
#2949Methods and Compositions for Inducing Deregulation of EPHA7 and ERK Phosphorylation in Human Acute Leukemias
#2950Methods for treating ischemia-reperfusion injury
#2951Methods of treating thyroid eye disease
#2952Methods and compositions for selecting siRNA of improved functionality
#2953Compositions and methods for inhibiting expression of mutant EGFR gene
#2954Methods of identifying and treating poor prognosis cancers
#2955Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
#2956REDUCING NONSENSE-MEDIATED MRNA DECAY
#2957Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#2958Antisense oligonucleotides with improved pharmacokinetic properties
#2959Methods for treating and/or limiting development of diabetes
#2960Methods and compositions for selecting siRNA of improved functionality
#2961CELL DEATH-INDUCING AGENT, CELL GROWTH-INHIBITING AGENT, AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DISEASE CAUSED BY ABNORMAL CELL GROWTH
#2962Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
#2963Methods and Compositions for the Treatment of Prostate Related Disorders using miR-1
#2964Composition for reducing senescence of cell or subject comprising smurf2 inhibitor and use thereof
#2965Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#2966Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
#2967Nucleic acid-encapsulating polymer micelle complex and method for producing same
#2968Anticancer combinations
#2969Fidgetin-like 2 as a target to enhance wound healing
#2970Compositions and methods for increasing erythropoietin (EPO) production
#2971Conserved HBV and HCV sequences useful for gene silencing
#2972Methods and compositions for the specific inhibition of HIF-1α by double-stranded RNA
#2973MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
#2974Channel modulators
#2975MPS peptides and use thereof
#2976Peptide sequence design and use thereof for peptide-mediated siRNA delivery
#2977Targeted Nanocarrier Systems for Delivery of Actives Across Biological Membranes
#2978Methods and compositions using miR-3151 in the diagnosis and treatment of thyroid cancer
#2979Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids
#2980TRPM4 channel inhibitors for stroke treatment
#2981Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders
#2982COMPOSITION AND VACCINE FOR TREATING LUNG CANCER
#2983SiRNA phospholipid conjugate
#2984Modulation of axon degeneration
#2985Methods and compositions for treating autoimmune disorders by targeting Kv1.3 ion channels with functionalized lipid-derived nanovesicles
#2986METHODS OF TREATING CANCER AND PREVENTING CANCER DRUG RESISTANCE
#2987DEVICE AND METHOD FOR THE DELIVERY OF DRUGS FOR THE TREATMENT OF POSTERIOR SEGMENT DISEASE
#2988Combination therapies for the treatment of Alzheimer's disease and related disorders
#2989Combination therapies for the treatment of alzheimer's disease and related disorders
#2990Compositions and methods for efficacious and safe delivery of siRNA using specific chitosan-based nanocomplexes
#2991Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitor
#2992Aptamers and use of the aptamers in the diagnosis and treatment of cancer
#2993Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
#2994COMPOUND ADMINISTRATION PRECURSOR AND MEDICAMENT CARRIER PREPARATION
#2995Compounds and methods for modulating apolipoprotein C-III expression for improving a diabetic profile
#2996Low density lipoprotein receptor-mediated siRNA delivery
#2997Cell-penetrating peptide, conjugate comprising same and composition comprising same
#2998PEPTIDES USEFUL AS CELL-PENETRATING PEPTIDES
#2999Bacterial Ribonucleic Acid Cell Wall Compositions and Methods of Making and Using Them
#3000Compositions and methods for treating alzheimer's disease and other tauopathies